9. Orthofix Medical
2018 revenue: $453.0 million
Orthofix Medical stock (NSDQ:OFIX) fell by nearly a fifth in value in late February and early March after the Lewisville, Texas–based company failed to meet Wall Street analysts’ expectations for its fourth-quarter and 2018 sales.
The company had some good news in recent weeks, however. People implanted with Orthofix’s M6-C artificial cervical disc showed a significant improvement in neck and arm pain, function and quality-of-life scores, according to an investigational device exemption (IDE) study.